NIKKEI 225
38,202.37 -632.73 (-1.63%) HANG SENG
18,313.86 -165.51 (-0.90%) CRUDE OIL
79.24 +0.25 (+0.32%) GOLD FUTURES
2,315.70 -6.60 (-0.28%) DOW
39,056.39 +172.13 (+0.44%) Bitcoin GBP
48,760.48 -1,105.16 (-2.22%)
Fresenius Medical Care AG (FMCQF)
| Previous close | 41.90 |
| Open | 42.00 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 42.00 - 42.00 |
| 52-week range | 34.33 - 49.86 |
| Volume | |
| Avg. volume | 119 |
| Market cap | 12.323B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 23.60 |
| EPS (TTM) | 1.78 |
| Earnings date | 30 Jul 2024 |
| Forward dividend & yield | 1.28 (3.06%) |
| Ex-dividend date | 17 May 2024 |
| 1y target est | N/A |
Insider MonkeyFresenius Medical Care AG & Co. KGaA (NYSE:FMS) Q1 2024 Earnings Call Transcript
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Q1 2024 Earnings Call Transcript May 7, 2024 Fresenius Medical Care AG & Co. KGaA beats earnings expectations. Reported EPS is $0.36, expectations were $0.26. Fresenius Medical Care AG & Co. KGaA isn’t one of the 30 most popular stocks among hedge funds at the end of […]
ZacksFresenius Medical (FMS) Q1 Earnings Beat, Operating Margin Up
Fresenius Medical's (FMS) first-quarter revenues suffer due to unfavorable currency movement. However, the company's transformational plans continue to benefit its operating income.
- Reuters
UPDATE 2-Fresenius raises outlook on strong quarterly results, exits Vamed
German healthcare group Fresenius first-quarter results beat expectations, the company said on Wednesday, citing strong performance at its Kabi and Helios businesses, prompting it to raise its full-year outlook. First-quarter earnings before interest and tax (EBIT) were 633 million euros ($680 million), above analysts' expectations of 606 million euros, according to a consensus of forecasts from Vara Research. In a bid to get leaner, Fresenius also said that it would sell its investment unit, Fresenius Vamed, completing its portfolio restructuring.
